Novartis to buy remaining Chiron shares in $5.1 billion deal
Novartis said it is buying the 58 percent of biopharmaceuticals company Chiron that it doesn’t already own for $5.1 billion.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.